Ghisallo Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Ghisallo Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,000	Closed	-$328K	–	170
2023 Q3	$328K	Hold	25,000	–	–	0.03%	104
2023 Q2	$640K	Hold	25,000	–	–	0.08%	103
2023 Q1	$630K	Buy	+25,000	New	+$587K	0.15%	52
2021 Q4	–	Sell	-15,000	Closed	-$404K	–	522
2021 Q3	$404K	Sell	15,000 -135,000	-90%	-$3.71M	0.02%	410
2021 Q2	$4.69M	Buy	+150,000	New	+$4.77M	0.18%	156

Other funds holding TMCI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ghisallo Capital Management's TMCI Position: Q4 2023 in Review

Ghisallo Capital Management sold out of Treace Medical Concepts (TMCI) in Q4 2023, closing a stake of 25,000 shares — an estimated $328K sold.

Ghisallo Capital Management first reported a position in TMCI in Q2 2021 and held it in 5 quarters. The position peaked at $4.69M in Q2 2021. 127 funds tracked by Wall St. Rank hold TMCI as of Q4 2023.

Ghisallo Capital Management reported no remaining Treace Medical Concepts position as of Q4 2023 after selling out during the quarter.
Ghisallo Capital Management sold 25,000 Treace Medical Concepts shares in Q4 2023, an estimated $328K.
Ghisallo Capital Management first reported a position in Treace Medical Concepts in Q2 2021 and held it in 5 quarters.
Ghisallo Capital Management's Treace Medical Concepts position peaked at $4.69M in Q2 2021.
127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2023.

Based on Ghisallo Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.